Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease

Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease

Both continuous oxidative stress and poly (ADP-ribose) polymerase 1 (PARP-1) activation occur in neurodegenerative diseases such as Parkinson's disease. PARP-1 inhibition can reverse mitochondrial damage and has a neuroprotective effect. In a previous study, we synthesized melatonin derivative...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing-Wei Ma (Author), Rui-Ting Han (Author), Zi-Jie Wu (Author), Jun-Jie Zhou (Author), Meng-Ting Chen (Author), Xiang-Zhi Zhang (Author), Wen-Zhe Ma (Author), Na Feng (Author)
Format: Book
Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items